Thursday, November 14
Danto Auditorium
12:00pm - 1:00pm
Innovation Grand Rounds
2:30pm-3:00pm
Refreshments & Poster Session
3:00pm-5:00pm
Innovation Challenge Pitch Event
|
|
Thursday, November 21
10:00am-11:00am
Webinar
|
|
|
MTRAC for Life Sciences Funding Gearing Up for Next Round
|
|
The
Mi-TRAC mid-stage funding RFP recently closed, and FFMI received 20 applications for the 2020 cycle. Applications came from U-M (Medical School, Dental School, LS&A, and Pharmacy), Michigan State University, Grand Valley State University/Spectrum Health, Wayne State University/Henry Ford Health System, and Western Michigan University. Awardees will be announced in January.
Mi-TRAC Awards are part of the
MTRAC for Life Sciences Innovation Hub - a statewide program that accelerates the transfer of technologies from Michigan's institutions of higher education to the private sector for commercialization. Mi-TRAC is co-administered with the U-M Office of Technology Transfer and generously supported by the Michigan Economic Development Corporation.
|
|
Michigan Economic Development Corporation Wins
Award for MTRAC
|
|
The Michigan Economic Development Corporation (MEDC) was recently recognized with four awards at the International Economic Development Council annual conference in Indianapolis. The awards highlight Michigan's business climate as one of the most favorable in the Midwest.
One of the awards MEDC received was a Gold Award for the Michigan Translational Research and Commercialization Program (MTRAC) Program. The MEDC generously supports the MTRAC for Life Sciences Innovation Hub at U-M. Congratulations!
|
|
Commercialization Education
|
|
Empowering Innovators at the Frankel Cardiovascular Center
|
|
The FCVC Innovation Challenge, taking place on Thursday, November 14, is an annual pitch competition where four to five teams who submitted top ideas impacting cardiovascular care compete for up to $100,000 in funding.
This exciting event is run much like an episode of "Shark Tank," where the teams pitch their idea to the judges. Anyone at the FCVC - faculty, staff, trainees, patients, and families - is eligible to submit ideas and attend the event.
|
|
FFMI Offers Drug Discovery and Development Course
First-of-its-Kind Collaboration with the Novartis Institute for BioMedical Research
|
|
Tuesday, November 19 & Wednesday, November 20
8:00am-5:00pm (each day)
NCRC Building 10
G063/G064 (Day 1) G065 (Day 2)
Seating is Limited!
Early to mid-career faculty or principal investigators will be assigned roles on a project team and tasked with the discovery and development of new medicine. Participants must commit to the full two-day program.
|
|
FFMI/FCVC Innovation Academy Now Accepting Applications
|
|
The FFMI/FCVC Aikens Innovation Academy is currently accepting applications/inquiries about its Winter 2020 class, which starts in January. The Aikens Innovation Academy is open to FCVC faculty, staff, and trainees with any innovation (clinical value or commercial potential) affecting cardiovascular care.
Along with the ten-week course on innovation concepts and pitch development, the Aikens Innovation Academy provides mentorship and an opportunity for early-stage development funding. Visit the
Aikens Innovation Academy course page to view the syllabus and to enroll.
|
|
11th Cohort of FFMI
fast
PACE Course Wraps Up
|
|
FFMI recently ended the 11th cohort of the
FFMI
fast
PACE Course with a competition in which eight of the ten FFMI
fastPACE teams from the University of Michigan, Michigan State University, and Wayne State University pitched their projects to the class and a panel of judges. The project teams graduated from the 4-week program that is designed to provide the knowledge and tools needed to navigate the initial process of innovation and commercialization.
The winners were:
1st place: Courtney Townsel and Hannah Floyd - University of Michigan
2nd place: Jennifer Meddings, Jessica Ameling, and Zizhang Zhang - University of Michigan
3rd place: Erik Martinez-Hackert and Monique Floer - Michigan State University
Crowd Favorite: Courtney Townsel and Hannah Floyd - University of Michigan
Congratulations to the winning project teams!
|
|
Michelle Larkin, FFMI Director of Commercialization Programs, and Sara Risch, Biomedical Innovation Specialist, attended the
Women Who Fund Forum on October 24, sponsored by ACG Detroit Women's Forum and University of Michigan Center for Venture Capital & Private Equity Finance, Ross School of Business. At the event, Michelle hosted a fireside chat with Mina Sooch, CEO & Co-founder of Ocuphire Pharma.
|
|
|
Asahi Kasei Pharma Looking to Collaborate on Drug Development
|
|
Asahi Kasei Pharma
is publicly calling for new proposals related to drug development research as part of its efforts
for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world.
Research areas of focus are chronic pain and neurodegenerative disease, autoimmune disease, critical care medicine, bone and/or cartilage disease, muscle-related disease, core technologies for drug discovery.
The application period begins on January 7, 2020 at 5:00am GMT (12:01am EST), and ends at 8:00am GMT (3:00am EST) on February 26, 2020.
|
|
|
To better navigate the complexities of the U-M biomedical research enterprise, visit the
Research Project Lifecycle
. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.
|
|
Fast Forward Medical Innovation
is part of the Office of Research, where our mission is to foster an environment of innovation and efficiency that serves the U-M Medical School community and supports biomedical science from insight to impact.
|
|
|
|
|
|
|
